Patient-reported outcomes of neoadjuvant apalutamide (ARN-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) trial – a phase II trial

• X.Y. Yang,
• E.J. Aslim,
• T.W. Chong,
• J.S.P. Yuen,
• K.J. Tay,
• H.S.S. Ho,
• L.S. Lee

Affiliations

X.Y. Yang

E.J. Aslim

T.W. Chong

J.S.P. Yuen

K.J. Tay

H.S.S. Ho

L.S. Lee